Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical sildenafil for skin graft success after burn injury
IRCT20241024063488N3Phase 3Completed
- Sponsor
- Aja University of Medical Sciences
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of sildenafil in burn injury (2 arms), sponsored by Aja University of Medical Sciences. Primary endpoints: Graft success rate based on capillary filling, Graft success rate based on color and 1 more. Started Dec 2025; status: completed.
02
Drugs
sildenafil
03
Conditions
burn injury
Beyond the preview
Go deeper on IRCT20241024063488N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241024063488N3.